Host-autonomous regeneration as a goal of cell and gene therapy for intervertebral disc degeneration

Cell and gene therapies for intervertebral disc degeneration aim to restore tissue function, but cell survival, matrix accumulation and prolonged symptom improvement do not establish sustained regeneration. This Review examines recent evidence through host-autonomous regeneration: continued tissue renewal and functional maintenance by host-derived cells and their local microenvironment, with reduced dependence on a specified external therapeutic activity. We connect senescence-associated defects in genome maintenance, protein turnover and metabolism with impaired inflammatory clearance, progenitor depletion and regional mechanical constraints. These relationships explain why correcting one molecular response may leave synthesis, matrix retention or damage disposal inadequate. We compare endogenous gene regulation, donor-derived signalling and cell transplantation according to the functions they restore, and consider how materials, delivery and treatment timing support those functions. A deficit-directed approach is proposed in which additional components address demonstrated residual limitations rather than expand formulations without a defined purpose. Validation requires attribution of new matrix to its cellular source, measurement of effective treatment activity and assessment of tissue function under load. Human-relevant models and product-specific potency assays should connect these mechanisms with controlled patient outcomes. Host-autonomous regeneration remains a testable therapeutic objective. Persistent grafts, stable molecular correction and long-term material support may remain valuable, but their contributions must be resolved to explain what sustains repair and whether it benefits patients.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2026-11-19
DOI
https://doi.org/10.3389/fbioe.2026.2047254
Primary Topic
Spine and Intervertebral Disc Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Host-autonomous regeneration as a goal of cell and gene therapy for intervertebral disc degeneration

Wanxue Wang, Yusen Qiao, Chao Qi, Haowen Lu et al.
Frontiers in Bioengineering and Biotechnology
Spine and Intervertebral Disc Pathology
article

Host-autonomous regeneration as a goal of cell and gene therapy for intervertebral disc degeneration

Wanxue Wang, Yusen Qiao, Chao Qi, Haowen Lu, Junmiao Liu, Qinge Guo, Xia Zhao, Wei Sheng, Minsheng Zhu
article en

Abstract

Cell and gene therapies for intervertebral disc degeneration aim to restore tissue function, but cell survival, matrix accumulation and prolonged symptom improvement do not establish sustained regeneration. This Review examines recent evidence through host-autonomous regeneration: continued tissue renewal and functional maintenance by host-derived cells and their local microenvironment, with reduced dependence on a specified external therapeutic activity. We connect senescence-associated defects in genome maintenance, protein turnover and metabolism with impaired inflammatory clearance, progenitor depletion and regional mechanical constraints. These relationships explain why correcting one molecular response may leave synthesis, matrix retention or damage disposal inadequate. We compare endogenous gene regulation, donor-derived signalling and cell transplantation according to the functions they restore, and consider how materials, delivery and treatment timing support those functions. A deficit-directed approach is proposed in which additional components address demonstrated residual limitations rather than expand formulations without a defined purpose. Validation requires attribution of new matrix to its cellular source, measurement of effective treatment activity and assessment of tissue function under load. Human-relevant models and product-specific potency assays should connect these mechanisms with controlled patient outcomes. Host-autonomous regeneration remains a testable therapeutic objective. Persistent grafts, stable molecular correction and long-term material support may remain valuable, but their contributions must be resolved to explain what sustains repair and whether it benefits patients.

Frontiers in Bioengineering and BiotechnologyVol. 14
Qingdao University (CN), Affiliated Hospital of Qingdao University (CN), Hubei Polytechnic University (CN), First Affiliated Hospital of Soochow University (CN), Huangshi Central Hospital (CN)
Spine and Intervertebral Disc Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon